{"id":"W2162227144","doi":"10.3747/co.v17i6.670","title":"Consensus Recommendations for the Use of Anti-EGFR Therapies in Metastatic Colorectal Cancer","year":2010,"lang":"en","type":"article","venue":"Current Oncology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University Health Centre; CancerCare Manitoba; Saskatchewan Cancer Agency; Queen Elizabeth II Health Sciences Centre; Ottawa Hospital; BC Cancer Agency; Hôpital Charles-Le Moyne","funders":"","keywords":"Cetuximab; Medicine; Panitumumab; KRAS; Irinotecan; Colorectal cancer; Oncology; Internal medicine; EGFR inhibitors; Oxaliplatin; Tolerability; Epidermal growth factor receptor; Targeted therapy; Cancer; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.05317725,0.001521219,0.002859813,0.006331816,0.003001802,0.003070029,0.01158574,0.01123903,0.004619419],"category_scores_gemma":[0.08316415,0.001185786,0.006197914,0.005135677,0.002095085,0.002772501,0.003770329,0.01559059,0.003545398],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01110851,"about_ca_system_score_gemma":0.04810027,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.04977251,"about_ca_topic_score_gemma":0.06815194,"domain_scores_codex":[0.9545119,0.01824849,0.01078054,0.001104974,0.01316207,0.002191986],"domain_scores_gemma":[0.8722885,0.02220788,0.007890072,0.001887926,0.08844454,0.00728101],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001763335,0.0002776976,0.001819277,0.006476945,0.0002600099,0.001007909,0.001208935,0.002085931,0.0009174022,0.01116112,0.7060033,0.2686052],"study_design_scores_gemma":[0.0003323269,0.0002096071,0.004433411,0.02081644,0.0005432923,0.0009913994,0.001304412,0.001140393,0.0006876697,0.01159521,0.9577727,0.0001730639],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"other","genre_scores_codex":[0.003403191,0.1263002,0.04776174,0.7127314,0.03323283,0.004869636,0.00300097,0.0007301487,0.06796981],"genre_scores_gemma":[0.05163018,0.1788061,0.4796439,0.2245766,0.009640649,0.01145265,0.01206281,0.0003748488,0.03181236],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.05317725,"threshold_uncertainty_score":0.2812315,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2742577407527562,"score_gpt":0.469060729860102,"score_spread":0.1948029891073458,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}